K. Abdel-kader, M. L. Unruh, and S. D. Weisbord, Symptom Burden, Depression, and Quality of Life in Chronic and End-Stage Kidney Disease, Clin. J. Am. Soc. Nephrol, 2009.

A. Sante, Diagnostic de l'insuffisance rénale chronique chez l'adulte. Recommandations pour la pratique clinique, 2002.

A. Medicament, , 2017.

A. Medicament, , 2017.

, specid=67482372&typedoc=R#Rcp PropPharmacodynamiques AGENCE NATIONALE DE SECURITE DU MEDICAMENT, 2017.

A. Medicament, Fentanyl, 2017.

A. Medicament, Nalbuphine, 2016.

A. Medicament, , 2016.

A. Medicament, , 2014.

A. Medicament, , 2013.

A. Medicament, , 2011.

A. Medicament, , 2010.

A. Medicament, Douleur rebelle en situation palliative avancée chez l'adulte, 2010.

A. Medicament, , 2009.

E. Aitken, A. Mclellan, J. Glen, and M. Serpell, Pain resulting from arteriovenous fistulae: prevalence and impact, Clin. Nephrol, vol.80, pp.328-333, 2013.

P. Alfonsi and M. Chauvin, Néfopam : quelles limites d'utilisation ?, 2004.

N. D. Ameli-sante, Qu'est-ce que la maladie rénale chronique ?

A. Html, M. Buhrer, M. Lotsch, and J. , Insidious Intoxication After Morphine Treatment in Renal Failure: Delayed Onset of Morphine-6-glucuronide Action, Anesthesiology, vol.92, pp.1473-1476, 2000.

J. F. Arnould and M. Pinaud, Pharmacologie de la nalbuphine, Ann Fr Anesth Reanim, vol.11, pp.221-228, 1992.

A. J. Atkinson, J. Fudin, E. Wegrzyn, and J. J. Bettinger, Dialysis, opioids, and pain management: Where's the evidence? Pract. Pain Manag, pp.49-57, 2014.

N. Babul and A. C. Darke, Putative role of hydromorphone metabolites in myoclonus, Pain, vol.51, pp.260-261, 1992.

G. R. Bailie, N. A. Mason, J. L. Bragg-gresham, and B. Gillespie, Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription, Kidney Int, vol.65, pp.2419-2425, 2004.

A. Barakzoy and A. Moss, Efficacy of the World Health Organization Analgesic Ladder to Treat Pain in End-Stage Renal Disease, J. Am. Soc. Nephrol, vol.17, pp.3198-3203, 2006.

J. N. Barnes, A. J. Williams, M. J. Tomson, and F. J. Goodwin, Dihydrocodeine in renal failure : further evidence for an important role of the kidney in the handling of opioid drugs, Br Med J Clin Res Ed, vol.290, pp.740-742, 1985.

A. Berquin, Progrès récents dans le diagnostic et le traitement du syndrome douloureux régional complexe, Rev Med Suisse, vol.4, 2008.

P. Bertin, P. Vergne-salle, and C. Dufauret-lombard, Opioïdes forts et douleurs chroniques non cancéreuses rhumatologiques. Médecine, vol.4, pp.10-13, 2008.

A. Bhagyashree, S. Manikkoth, M. Sequeira, and R. Nayak, Central dopaminergic system plays a role in the analgesic action of paracetamol: Preclinical evidence, Indian J Pharmacol, vol.49, pp.21-25, 2017.

Y. M. Binik, A. G. Baker, D. Kalegeropoulos, and G. Devins, Pain, control over treatment, and compliance in dialysis and transplant patients, Kidney Int, vol.21, pp.840-848, 1982.

T. Bouattar, Z. Skalli, H. Rhou, and F. Ezzaitouni, Evaluation et analyse des douleurs chez les hémodialysés chroniques, Nephrol. Thérapeutique, vol.5, pp.637-641, 2009.

F. Bourbonnais and K. Tousignant, The Pain Experience of Patients On Maintenance Hemodialysis, Nephrol. Nurs. J, vol.39, pp.13-19, 2012.

V. Bourquin and A. Petignat, Analgésie et insuffisance rénale, Rev. Médicale Suisse, pp.2218-2223, 2008.

T. Brkovic, E. Burilovic, and L. Puljak, Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review, Patient Prefer. Adherence, vol.10, pp.1131-1150, 2016.

B. Calvino, L'hypersensibilité à la chaleur au cours de l'inflammation: le rôle du récepteur TRPV1, Med Sci, pp.649-651, 2003.

R. Centre and . France, Qu'est ce qu'un effet indésirable?, 2016.

S. Chen, S. Al-mawed, and M. L. Unruh, Health-Related Quality of Life in End-Stage Renal Disease Patients: How Often Should We Ask and What Do We Do with the Answer?, Blood Purif, vol.41, pp.218-224, 2016.

R. N. Claxton, L. Blackhall, S. D. Weisbord, and J. L. Holley, Undertreatment of Symptoms in Patients on Maintenance Hemodialysis, J. Pain Symptom Manage, vol.39, pp.211-218, 2010.

D. W. Cockroft and M. H. Gault, Prediction of creatinine clearance from serum creatinine, Nephron, vol.16, pp.31-41, 1976.

. Cour and . Comptes, Rapport sur l'application des lois de financement de la sécurité sociale. Chapitre X -L'insuffisance rénale chronique terminale : favoriser des prises en charge plus efficientes, 2015.

S. N. Davison, Pain in hemodialysis patients: prevalence, cause, severity, and management, Am J Kidney Dis, pp.1239-1247, 2003.

S. N. Davison and G. S. Jhangri, Impact of Pain and Symptom Burden on the Health-Related Quality of Life of Hemodialysis Patients, J. Pain Symptom Manage, vol.39, pp.477-485, 2010.

S. N. Davison, H. Koncicki, and F. Brennan, Pain in Chronic Kidney Disease: A Scoping Review, Semin. Dial, vol.27, pp.188-204, 2014.

M. Dean, Opioids in renal failure and dialysis patients, J. Pain Symptom Manage, vol.28, pp.497-504, 2004.

G. D'honneur, A. Gilton, P. Sandouk, and J. M. Scherrmann, Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure, Anesthesiology, vol.81, pp.87-93, 1994.

R. El-harraqui, N. Abda, and I. Haddiya, Evaluation et analyse de la douleur en hémodialyse chronique, Nephrol. Thérapeutique, vol.10, pp.500-506, 2014.

E. Society and . Cardiology, Guidelines for the Management of dyslipidaemias, Eur. Heart J, vol.37, pp.2999-3058, 2016.

R. Feldman, N. Berman, M. C. Reid, and J. Roberts, Improving Symptom Management in Hemodialysis Patients: Identifying Barriers and Future Directions, J. Palliat. Med, vol.16, pp.1528-1533, 2013.

P. A. Foral, J. R. Ineck, and K. K. Nystrom, Oxycodone Accumulation in a Hemodialysis Patient, South. Med. J, vol.100, pp.212-214, 2007.

S. Gabardi and S. Abramson, Drug Dosing in Chronic Kidney Disease, Chronic Kidney DiseaseChronic Kidney Disease, vol.89, pp.649-687, 2005.

C. Gamondi, N. Galli, C. Schonholzer, and C. Marone, Frequency and severity of pain and symptom distress among patients with chronic kidney disease receiving dialysis, Swiss Med. Wkly, p.143, 2013.

T. Ghonemy, Chronic Pain in hemodialysis patients : Role of bone mineral metabolism, Alex. J. Med, pp.337-342, 2016.

, Rein -adaptation posologique, 2017.

S. Greneche, A. D'andon, C. Jacquelinet, and B. Faller, Le choix entre dialyse péritonéale et hémodialyse : une revue critique de la littérature, pp.213-220, 2005.

. Haute-autorite-de and . Sante, Maladie rénale chronique de l'adulte -Parcours de soins, 2012.

. Haute-autorite-de and . Sante, Diagnostic de l'insuffisance rénale chronique, 2012.

A. Hawi, H. J. Alcorn, J. Berg, and C. Hines, Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus, BMC Nephrol, vol.16, p.47, 2015.

. Hopitaux and . De-geneve, Transplantation rénale -Service de néphrologie à Genève aux HUG

H. J. Hsu, C. H. Yen, I. W. Wu, C. Lee, P. Jungers et al., Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease, BMC Nephrology, vol.15, p.96, 2011.

R. Kaiko, D. Benziger, C. Cheng, and Y. Hou, Clinical Pharmacokinetics of Controlled-Release Oxycodone in Renal Impairment, Oxycodone. J. Pain Symptom Manage, vol.59, pp.47-56, 1996.

B. Kieffer, H. Matthes, and R. Maldonado, Mini-synthèse : Mécanisme d'action de la morphine, pp.232-235, 1997.

S. Klahr, A. S. Levey, G. J. Beck, and A. W. Caggiula, The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease, N. Engl. J. Med, vol.330, pp.877-884, 1994.

H. Koncicki, F. Brennan, K. Vinen, and S. N. Davison, An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms, Semin. Dial, pp.384-391, 2015.

J. Lagas, J. Wagenaar, A. Huitema, and M. Hillebrand, Lethal morphine intoxication in a patient with a sickle cell crisis and renal impairment: case report and a review of the literature, Hum. Exp. Toxicol, vol.30, pp.1399-1403, 2011.

V. Launay-vacher, S. Karie, J. Fau, and H. Izzedine, Treatment of pain in patients with renal insufficiency: The World Health Organization three-step ladder adapted, J. Pain, vol.6, pp.137-148, 2005.

C. Legendre, La transplantation rénale, 2011.

A. S. Levey, L. A. Stevens, C. H. Schmid, and Y. L. Zhang, A new equation to estimate glomerular filtration rate, Ann. Intern. Med, vol.150, pp.604-612, 2009.

J. Lo and J. Cavazos, Management of complex regional pain syndrome, Proc Bayl Univ Med Cent, vol.30, pp.286-288, 2017.

E. Mambelli, M. Barella, M. G. Facchini, and E. Mancini, The prevalence of peripheral neuropathy in hemodialysis patients, Clin. Nephrol, vol.77, pp.468-475, 2012.

V. Martinez, N. Attal, D. Bouhassira, and M. Lanteri-minet, Les douleurs neuropathiques chroniques : diagnostic, évaluation et traitement en médecine ambulatoire. Recommandations pour la pratique clinique de la Société française d'étude et de traitement de la douleur, 2010.

H. Merskey and N. Bogduk, Classification of chronic pain, IASP Task Force on Taxonomy. Int. Assoc, 1994.

W. Michels, D. Grootendorst, M. Verduijn, and E. Elliott, Performance of the Cockcroft-Gault, MDRD, and New CKD-EPI Formulas in Relation to GFR, Age, and Body Size, Clin. J. Am. Soc. Nephrol, vol.5, pp.1003-1009, 2010.

O. Mimoz, S. Chauvet, N. Gregoire, and S. Marchand, Nefopam Pharmacokinetics in Patients with End-Stage Renal Disease, Anesth. Analg, vol.111, pp.1146-1153, 2010.

S. Muramatsu, S. Shiraishi, and K. Miyano, Metabolism of AM404 From Acetaminophen at Human Therapeutic Dosages in the Rat Brain, Anesth Pain Med, vol.6, 2016.

E. Murphy, F. Murtagh, and I. Carey, Understanding Symptoms in Patients with Advanced Chronic Kidney Disease Managed without Dialysis: Use of a Short Patient-Completed Assessment Tool, Nephron Clin Pr, vol.111, pp.74-80, 2009.

A. Murray and N. Hagen, Hydromorphone. J. Pain Symptom Manage, vol.29, pp.57-66, 2005.

F. Murtagh, J. Addington-hall, and I. J. Higginson, The prevalence of symptoms in end-stage renal disease: a systematic review, Adv. Chronic Kidney Dis, vol.14, pp.82-99, 2007.

V. Naggar, P. Birthi, and S. Salles, Opioid Use in Chronic Pain Patients with Chronic Kidney Disease : A systematic Review, Pain Med, vol.0, pp.1-34, 2017.

. National and . Diseases, Clinical Practice Guidelines For the Chronic Kidney Disease : Evaluation, Classification and Stratification, NATIONAL KIDNEY FOUNDATION DISEASE OUTCOME QUALITY INITIATIVE, 2002.

I. Noack, M. Fourtage, A. Dory, and Y. Dimitrov, Evaluation régionale des pratiques des néphrologues lors de la prescription de morphiniques, 2017.

H. Noble, J. Meyer, and J. Bridge, Exploring symptoms in patients managed without dialysis : a qualitative research study, J. Ren. Care, vol.36, pp.9-15, 2010.

T. Nolin, A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD, Semin. Dial, vol.28, pp.325-329, 2015.

T. Nolin, K. Appiah, S. A. Kendrick, and P. Le, Hemodialysis Acutely Improves Hepatic CYP3A4 Metabolic Activity, J. Am. Soc. Nephrol, vol.17, pp.2363-2367, 2006.

T. Nolin, R. F. Frye, and G. R. Matzke, Hepatic drug metabolism and transport in patients with kidney disease, Am. J. Kidney Dis, vol.42, pp.906-925, 2003.

T. Nolin, J. Naud, F. Leblond, and V. Pichette, Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport, Clin. Pharmacol. Ther, vol.83, pp.898-903, 2008.

G. Paramanandam, E. Prommer, and D. C. Schwenke, Adverse Effects in Hospice Patients with Chronic Kidney Disease Receiving Hydromorphone, J. Palliat. Med, vol.14, pp.1029-1033, 2011.

W. Peter, K. Redic-kill, and C. Halstenson, Clinical Pharmacokinetics of Antibiotics in Patients with Impaired Renal Function, Clin. Pharmacokinet, vol.22, pp.169-210, 1992.

R. Epidemiologie, . Information, and . Nephrologie, , 2014.

M. Roy, J. J. Bettinger, E. Wegrzyn, and J. Fudin, Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease, J. Pain Res, pp.1191-1195, 2016.

G. Rudkin and G. Osborn, Intra-operative patient-controlled sedation. Comparison of patient-controlled propofol with patient-controlled midazolam, Anesthesia, vol.47, pp.376-381, 1992.

D. Santoro, E. Satta, S. Messina, and G. Costantino, Pain in end-stage renal disease : a frequent and neglected clinical problem, Clin. Nephrol, vol.78, pp.2-11, 2012.

N. Schaad, J. W. Sear, C. W. Hand, R. A. Moore, and H. J. Mc-quay, Studies on morphine disposition : influence of renal failure on the kinetics of morphine and its metabolites, Br. J. Anaesth, vol.3, pp.28-32, 1989.

S. Skevington, Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL, Pain, vol.76, pp.395-406, 1998.

D. Societe-francaise and . Douleur, Utilisation des opioïdes forts dans la douleur chronique non cancéreuse chez l'adulte, 2016.

. Societe-francophone-de-nephrologie-dialyse-et-transplantation,-n.d.-l'hémodialyse,

L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey, Assessing Kidney Function -Measured and Estimated Glomerular Filtration Rate, N. Engl. J. Med, vol.354, pp.2473-2483, 2006.

P. Tremblay, Mécanisme d'action et de toxicité de l'acétaminophène. Inst. Natl. Santé Publique Qué, p.27, 2011.

P. Vergne-salle, F. Laroche, and A. Bera-louville, Les opioïdes forts dans les douleurs ostéo-articulaires non cancéreuses : revue de la littérature et recommandations pour la pratique clinique, Les recommandations de Limoges, vol.13, pp.259-275, 2010.

N. Vidal, Résumé des caractéristiques du produit -Morphine

A. W. Williams, A. C. Dwyer, A. Eddy, and J. C. Fink, Critical and Honest Conversations: The Evidence Behind the "Choosing Wisely" Campaign Recommendations by the, Clin. J. Am. Soc. Nephrol, vol.7, pp.1664-1672, 2012.

A. Wyne, R. Rai, M. Cuerden, and W. F. Clark, Opioid and benzodiazepine use in end-stage renal disease: a systematic review, Clin. J. Am. Soc. Nephrol. CJASN, vol.6, pp.326-333, 2011.

M. Zhan, W. L. St-peter, and R. Doerfler, Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD, Clin J Am Soc Nephrol, vol.12, pp.1-9, 2017.

S. Zyga, V. Alikari, A. Sachlas, and J. Stathoulis, Management of Pain and Quality of Life in Patients with Chronic Kidney Disease Undergoing Hemodialysis, Pain Manag. Nurs. Off. J. Am. Soc. Pain Manag. Nurses, vol.16, pp.712-720, 2015.

, accepte de participer à l'enquête : Enquête observationnelle sur l'efficacité et la tolérance des morphiniques chez le patient insuffisant rénal chronique terminal. Les objectifs et modalités de l'enquête m'ont été clairement expliqués, Je soussigné(e) ??????????????????????(nom et prénom)

, J'accepte que les documents de mon dossier médical qui se rapportent à l'enquête puissent être accessibles aux responsables de l'enquête. A l'exception de ces personnes, qui traiteront les informations dans le plus strict respect du secret médical, mon anonymat sera préservé

, J'accepte que les données nominatives me concernant recueillies à l'occasion de cette étude puissent faire l'objet d'un traitement automatisé par les organisateurs de l'enquête. Je pourrai exercer mon droit d'accès et de rectification auprès des organisateurs de l'enquête

, J'ai bien compris que ma participation à l'enquête est volontaire

, Je suis libre d'accepter ou de refuser de participer, et je suis libre d'arrêter à tout moment ma participation en cours d'enquête. Cela n'influencera pas la qualité des soins qui me seront prodigués

, Mon consentement ne décharge pas les organisateurs de cette enquête de leurs responsabilités

, Après en avoir discuté et avoir obtenu la réponse à toutes mes questions, j'accepte librement et volontairement de participer à la recherche qui m'est proposée